Current Ratio in % of Xilio Therapeutics, Inc. from Q2 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Xilio Therapeutics, Inc. quarterly Current Ratio history and change rate from Q2 2022 to Q3 2025.
  • Xilio Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 217 %, a 4.4% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Xilio Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 217 +9.17 +4.4% 30 Sep 2025
Q2 2025 205 -47.1 -18.7% 30 Jun 2025
Q1 2025 194 -128 -39.6% 31 Mar 2025
Q4 2024 200 -241 -54.6% 31 Dec 2024
Q3 2024 208 -308 -59.7% 30 Sep 2024
Q2 2024 252 -376 -59.9% 30 Jun 2024
Q1 2024 322 -410 -56% 31 Mar 2024
Q4 2023 441 -458 -51% 31 Dec 2023
Q3 2023 517 -639 -55.3% 30 Sep 2023
Q2 2023 628 -544 -46.4% 30 Jun 2023
Q1 2023 732 31 Mar 2023
Q4 2022 899 31 Dec 2022
Q3 2022 1.16K 30 Sep 2022
Q2 2022 1.17K 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.